EPRX

Eupraxia Pharmaceuticals
EPRX

9 hedge funds and large institutions have $5.63M invested in Eupraxia Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$37.6K
2
+$31.3K
3
+$23.5K

Top Sellers

1
-$15.8K
2
-$14K
3
-$7.92K
4
TWC
TD Waterhouse Canada
Ontario, Canada
-$3.83K
5
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$336
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$4.26M
2
$898K
3
$178K
4
$109K
5
$88.8K
6
$36.8K
7
$33.3K
8
$31.3K
9
$135
10
–